Dipal Doshi

CIK 1613084 · CEO · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.62M

Companies

3

Total Filings

46

Lifetime Open-Market Net

-$1.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRDA CEO 526,014 $6.46 $3.40M -$1.39M 40 2026-03-03
AZTA Director 9,703 $22.59 $219.2K $0 2 2026-02-06
AMICUS THERAPEUTICS, INC. (FOLD) Delisted SVP Strategy & Bus Dev 1,706 $14.49 $24.7K -$86.7K 4 2015-07-09

Recent Filings · Page 4 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-09-28 TRDA Sell (S) −10,587 -$161.4K EDGAR
2022-09-23 TRDA Sell (S) −4,425 -$66.8K EDGAR
2022-09-19 TRDA Sell (S) −200 -$3.0K EDGAR
2022-09-12 TRDA Sell (S) −1,788 -$27.0K EDGAR
2022-09-06 TRDA Grant (A) +15,125 $0 EDGAR
2022-08-31 TRDA Sell (S) −2,000 -$25.4K EDGAR
2022-07-29 TRDA Sell (S) −2,000 -$24.0K EDGAR
2022-07-06 TRDA Grant (A) $0 EDGAR
2022-06-29 TRDA Sell (S) −4,000 -$48.0K EDGAR
2022-03-03 TRDA Grant (A) +30,250 $0 EDGAR
Showing 3140 of 46
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.